targeting CXCL12/CXCR4 have been developed for leukemia treatment, it is essential to recognize that any aberrations (such as intrinsic genetic variations or external factors disrupting homeostasis) may contribute to leukemia initiation. Here, CXCL12 is linked to leukemia.